Trial of implantable contact lenses expanded
This article was originally published in Clinica
Staar Surgical is to begin Phase III clinical trials in the US of its implantable contact lenses (ICLs) for myopia after getting the go-ahead from the FDA. The Monrovia, California-based company will implant 278 additional ICL's in patients and expand its trials to include patients with myopia of three dioptres.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.